A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

405

Participants

Timeline

Start Date

October 6, 2021

Primary Completion Date

November 28, 2023

Study Completion Date

January 18, 2031

Conditions
Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
Interventions
DRUG

Imatinib

Comes in 100 mg and 400 mg tablets and taken orally

DRUG

Nilotinib

Comes in 150 mg and 200 mg capsules and taken orally

DRUG

Bosutinib

Comes in 100 mg and 400 mg tablets and taken orally

DRUG

Dasatinib

Comes in 20 mg, 50 mg, 70 mg and 100 mg tablets and taken orally

DRUG

Asciminib

Comes in 40 mg tablets and taken orally

Trial Locations (110)

1000

Novartis Investigative Site, Brussels

2444

Novartis Investigative Site, Port Macquarie

2747

Novartis Investigative Site, Kingswood

3000

Novartis Investigative Site, Leuven

4010

Novartis Investigative Site, Linz

4032

Novartis Investigative Site, Debrecen

4215

Novartis Investigative Site, Southport

5000

Novartis Investigative Site, Adelaide

6001

Novartis Investigative Site, Kecskemét

6850

Novartis Investigative Site, Bellinzona

7400

Novartis Investigative Site, Kaposvár

8200

Novartis Investigative Site, Aarhus N

9010

Novartis Investigative Site, Varna

10450

Novartis Investigative Site, George Town

11759

Novartis Investigative Site, Uijeongbu-si

13353

Novartis Investigative Site, Berlin

18014

Novartis Investigative Site, Granada

20122

Novartis Investigative Site, Milan

23538

Novartis Investigative Site, Lübeck

25100

Novartis Investigative Site, Kuantan

27157

Wake Forest University Baptist Medical Center, Winston-Salem

28046

Novartis Investigative Site, Madrid

30120

Novartis Investigative Site, El Palmar

31008

Novartis Investigative Site, Pamplona

32308

Florida Cancer Specialists Pan, Tallahassee

33076

Novartis Investigative Site, Bordeaux

33901

Florida Cancer Specialists, Fort Myers

37134

Novartis Investigative Site, Verona

37404

Chattanooga Onc And Hem Assoc PC, Chattanooga

40138

Novartis Investigative Site, Bologna

40447

Novartis Investigative Site, Taichung

40536

University of Kentucky, Lexington

42123

Novartis Investigative Site, Reggio Emilia

44093

Novartis Investigative Site, Nantes

47500

Novartis Investigative Site, Subang Jaya

52074

Novartis Investigative Site, Aachen

57105

Avera Cancer, Sioux Falls

60590

Novartis Investigative Site, Frankfurt am Main

68000

Novartis Investigative Site, Kuala Selangor

68305

Novartis Investigative Site, Mannheim

69373

Novartis Investigative Site, Lyon

75246

Texas Oncology-Baylor USO, Dallas

Texas Oncology, Dallas

75251

Texas Oncology, Dallas

75475

Novartis Investigative Site, Paris

80218

Rocky Mountain Cancer Centers, Denver

97239

Oregon Health Sciences University, Portland

97401

Williamette Cancer Center, Eugene

100044

Novartis Investigative Site, Beijing

100730

Novartis Investigative Site, Beijing

119074

Novartis Investigative Site, Singapore

169608

Novartis Investigative Site, Singapore

210000

Novartis Investigative Site, Nanjing

215004

Novartis Investigative Site, Suzhou

300020

Novartis Investigative Site, Tianjin

310003

Novartis Investigative Site, Hangzhou

325000

Novartis Investigative Site, Wenzhou

430022

Novartis Investigative Site, Wuhan

450008

Novartis Investigative Site, Zhengzhou

510515

Novartis Investigative Site, Guangzhou

518037

Novartis Investigative Site, Shenzhen

610041

Novartis Investigative Site, Chengdu

710068

Novartis Investigative Site, Xian

730000

Novartis Investigative Site, Lanzhou

4941492

Novartis Investigative Site, Petah Tikva

5265601

Novartis Investigative Site, Ramat Gan

6423906

Novartis Investigative Site, Tel Aviv

01655

Uni of Massachusetts Medical Center, Worcester

T2N 5G2

Novartis Investigative Site, Calgary

L8V 1C3

Novartis Investigative Site, Hamilton

K1H 8L6

Novartis Investigative Site, Ottawa

M5G 2M9

Novartis Investigative Site, Toronto

500 05

Novartis Investigative Site, Hradec Králové

708 52

Novartis Investigative Site, Ostrava

625 00

Novartis Investigative Site, Brno Bohunice

DK-2100

Novartis Investigative Site, Copenhagen

FIN 00290

Novartis Investigative Site, Helsinki

07740

Novartis Investigative Site, Jena

110 085

Novartis Investigative Site, Delhi

00161

Novartis Investigative Site, Roma

453-8511

Novartis Investigative Site, Nagoya

470 1192

Novartis Investigative Site, Toyoake

812-8582

Novartis Investigative Site, Fukuoka

960 1295

Novartis Investigative Site, Fukushima

060 8648

Novartis Investigative Site, Sapporo

650-0047

Novartis Investigative Site, Kobe

710-8602

Novartis Investigative Site, Kurashiki

589 8511

Novartis Investigative Site, Ōsaka-sayama

565 0871

Novartis Investigative Site, Suita

329-0498

Novartis Investigative Site, Shimotsuke

409-3898

Novartis Investigative Site, Chūō

010-8543

Novartis Investigative Site, Akita

545-8586

Novartis Investigative Site, Osaka

990 9585

Novartis Investigative Site, Yamagata

1081 HV

Novartis Investigative Site, Amsterdam

NO-5021

Novartis Investigative Site, Bergen

0372

Novartis Investigative Site, Oslo

4200-072

Novartis Investigative Site, Porto

4434 502

Novartis Investigative Site, Vila Nova de Gaia

041 90

Novartis Investigative Site, Košice

06591

Novartis Investigative Site, Seoul

03080

Novartis Investigative Site, Seoul

06351

Novartis Investigative Site, Seoul

08036

Novartis Investigative Site, Barcelona

413 45

Novartis Investigative Site, Gothenburg

221 85

Novartis Investigative Site, Lund

141 86

Novartis Investigative Site, Stockholm

W12 0HS

Novartis Investigative Site, London

NG5 1PB

Novartis Investigative Site, Nottingham

OX3 7LE

Novartis Investigative Site, Oxford

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY